| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles | Cancer Letters | 2004 | 1,746 |
| 2 | Circular RNA: A new star of noncoding RNAs | Cancer Letters | 2015 | 1,500 |
| 3 | Tumor microenvironment and therapeutic response | Cancer Letters | 2017 | 1,362 |
| 4 | Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles | Cancer Letters | 2006 | 1,267 |
| 5 | Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury | Cancer Letters | 2012 | 1,079 |
| 6 | Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice | Cancer Letters | 2008 | 1,057 |
| 7 | Long non-coding RNAs: A new frontier in the study of human diseases | Cancer Letters | 2013 | 1,057 |
| 8 | The insulin-like growth factor system and cancer | Cancer Letters | 2003 | 1,009 |
| 9 | Curcumin and cancer: An “old-age” disease with an “age-old” solution | Cancer Letters | 2008 | 978 |
| 10 | Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings | Cancer Letters | 1987 | 961 |
| 11 | Anti-tumour and antioxidant activity of natural curcuminoids | Cancer Letters | 1995 | 960 |
| 12 | Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Cancer Letters | 2008 | 945 |
| 13 | HDAC family: What are the cancer relevant targets? | Cancer Letters | 2009 | 907 |
| 14 | Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy | Cancer Letters | 2020 | 877 |
| 15 | Circulating tumor cells (CTC) detection: Clinical impact and future directions | Cancer Letters | 2007 | 872 |
| 16 | Anthocyanins and their role in cancer prevention | Cancer Letters | 2008 | 858 |
| 17 | Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC | Cancer Letters | 1995 | 800 |
| 18 | p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents | Cancer Letters | 2014 | 800 |
| 19 | Chemopreventive and therapeutic effects of curcumin | Cancer Letters | 2005 | 786 |
| 20 | Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals | Cancer Letters | 2017 | 750 |
| 21 | DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis | Cancer Letters | 2013 | 738 |
| 22 | Bovine milk-derived exosomes for drug delivery | Cancer Letters | 2016 | 685 |
| 23 | Multitargeted cancer prevention by quercetin | Cancer Letters | 2008 | 639 |
| 24 | Tumor microenvironment: Sanctuary of the devil | Cancer Letters | 2015 | 630 |
| 25 | Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy | Cancer Letters | 2007 | 627 |
| 26 | Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer | Cancer Letters | 2017 | 626 |
| 27 | Helicobacter pylori-induced gastric inflammation and gastric cancer | Cancer Letters | 2014 | 623 |
| 28 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade | Cancer Letters | 2016 | 621 |
| 29 | Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth | Cancer Letters | 2013 | 620 |
| 30 | Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches | Cancer Letters | 2014 | 608 |
| 31 | The anti-inflammatory potential of berberine in vitro and in vivo | Cancer Letters | 2004 | 605 |
| 32 | Potential anticancer activity of turmeric (Curcuma longa) | Cancer Letters | 1985 | 577 |
| 33 | The role of CXC chemokines and their receptors in cancer | Cancer Letters | 2008 | 573 |
| 34 | The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism | Cancer Letters | 2015 | 567 |
| 35 | Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy | Cancer Letters | 2008 | 566 |
| 36 | Multi-targeted therapy of cancer by genistein | Cancer Letters | 2008 | 560 |
| 37 | Oxidative stress, DNA methylation and carcinogenesis | Cancer Letters | 2008 | 541 |
| 38 | Angiopoietins in angiogenesis | Cancer Letters | 2013 | 540 |
| 39 | Anoikis resistance and tumor metastasis | Cancer Letters | 2008 | 533 |
| 40 | Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression | Cancer Letters | 2013 | 532 |
| 41 | Role of aberrant crypt foci in understanding the pathogenesis of colon cancer | Cancer Letters | 1995 | 524 |
| 42 | Role of chemokines in tumor growth | Cancer Letters | 2007 | 524 |
| 43 | The inflammatory chemokines CCL2 and CCL5 in breast cancer | Cancer Letters | 2008 | 515 |
| 44 | Cancer related inflammation: The macrophage connection | Cancer Letters | 2008 | 511 |
| 45 | Cytochrome P450-mediated metabolism of estrogens and its regulation in human | Cancer Letters | 2005 | 497 |
| 46 | c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention | Cancer Letters | 2005 | 493 |
| 47 | Nrf2 as a novel molecular target for chemoprevention | Cancer Letters | 2005 | 479 |
| 48 | Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene | Cancer Letters | 2009 | 475 |
| 49 | Role of chemopreventive agents in cancer therapy | Cancer Letters | 2004 | 468 |
| 50 | CGCG clinical practice guidelines for the management of adult diffuse gliomas | Cancer Letters | 2016 | 468 |
